René S. Kahn

René Sylvain Kahn (born 1954) is a neuropsychiatrist and the Esther and Joseph Klingenstein Professor and System Chair of Psychiatry at the Icahn School of Medicine at Mount Sinai in the United States, a position he has held since 2017. He previously served as Professor of Psychiatry and Director of the Brain Center Rudolf Magnus at the University Medical Center Utrecht in the Netherlands. Kahn is recognized for his research on the neurobiology of schizophrenia. He served as a former president of the Schizophrenia International Research Society and was elected to the Royal Netherlands Academy of Arts and Sciences in 2009. He received the Neuropsychopharmacology Award from the European College of Neuropsychopharmacology in 2014.

He was awarded a knighthood in the Order of the Netherlands Lion in 2018. As of 2020, he was principal or co-principal investigator of more than 40 grants, written 39 books and book chapters and published more than 1000 peer-reviewed articles.

Kahn served in the Royal Netherlands Army as a first lieutenant in 1980 and 1981.

Following residencies in the Netherlands, he attended the Albert Einstein College of Medicine in New York City for a research fellowship in biological psychiatry. From there he completed psychiatry residencies at Mount Sinai Hospital and then acted as the chief of the psychiatry research unit at the Bronx VA Hospital. In 1993 he returned to the Netherlands be the chair of psychiatry at the University Medical Center. He led the Brain Center Rudolf Magnus —a multi-discipline center for research in fundamental neuroscience, psychiatry, neurology, neurosurgery and rehabilitation medicine—for over 10 years, until 2017.

Honors and awards

Fulbright Scholarship (1985) Lifetime achievement award of the Netherlands Psychiatric Association (2016) President of The Schizophrenia International Research Society (2014–2016) Fellow, American College of Neuropsychopharmacology Member of the Royal Netherlands Academy of Arts and Sciences (2009) Knight in the Order of the Netherlands Lion (2018)

Research Kahn studies biological causes of psychiatric disorders such as schizophrenia and has led numerous consortia examining the brain changes that play a role in schizophrenia.

Grants and trials As of 2020, Kahn is the principal investigator or co-principal investigator on 13 active grants related to child development and drug augmentation for onset schizophrenia to prevent psychosis and cognitive therapy symptoms.

Active grant in 2020:

+Grants, Contracts and Foundation SourcesTitle and No.RoleDurationStanley Foundation. Prednisolone augmentation for patients with recent onset schizophrenia PI2013-2020Stanley Foundation. Simvastatin augmentation for recent onset schizophrenia PI2013-2020EudraCT 2015-003503-39 Stanley Foundation. Omega fatty Data Integration and Computational Technologies PI2020-2024

Publications

Editorial As of 2020, Kahn is on the editorial board of Schizophrenia Research, European Neuropsychopharmacology, Schizophrenia Bulletin and Early Intervention in Psychosis.

Partial list:

.

.

. . .

Books and chapters Partial list:

Kahn RS. De appel en de Boom. Uitgeverij Balans, Amsterdam 2011. (3 editions) Kahn RS. In de spreekkamer van de psychiater. Uitgeverij Balans, Amsterdam 2008. , NUR 875 (6 printings) Kahn RS. Onze Hersenen., Over de smalle grens tussen normaal en abnormaal. Uitgeverij Balans, Amsterdam 2006, 2007, 2008. , NUR 875 (12 printings) De Haan L, Kahn RS. Psychotische stoornissen. In: Leerboek Psychiatrie (Hengeveld, van Balkom eds). De Tijdstroom uitgeverij, 2005. / 5898 094 4, NUR 875